Rheumatology-US

For US Healthcare Professional use only.
The safety and efficacy of these investigational agents have not been established.

Systemic Lupus Erythematosus

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus: A Randomized, Double-blind, Placebo-controlled, Phase 2, Proof-of-concept Study (APATURA)

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus: A Randomized, Double-blind, Placebo-controlled, Phase 2, Proof-of-concept Study (APATURA)

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus: A Randomized, Double-blind, Placebo-controlled, Phase 2, Proof-of-concept Study (APATURA)

Scan and Download Back

Privacy & Data Protection Cookies Policy
Does not include study cards for clinical programs of dupilumab.

MAT-US-2401225 v1.0 - P Exp. Date: 02/12/2026
© 2024 Sanofi. All rights reserved.